Luc Duchateau

Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902

Jos A. van der Hage, Cornelis J.�H. van de Velde, Jean‐Pierre Julien et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

Risk Factors for Recurrence and Metastasis After Breast-Conserving Therapy for Ductal Carcinoma-In-Situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853

Nina Bijker, Johannes L. Peterse, Luc Duchateau et al. · Journal of Clinical Oncology · 2001 · 497 citations

Calculating disability-adjusted life years to quantify burden of disease

Brecht Devleesschauwer, Arie H. Havelaar, Charline Maertens de Noordhout et al. · International Journal of Public Health · 2014 · 259 citations · Full text

Life Assessment, Aging, Health Policy +5

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer

Robert Paridaens, Luc Dirix, Caroline Lohrisch et al. · Annals of Oncology · 2003 · 230 citations

Metastatic Breast Cancer, Breast Oncology, Medicine +10

Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial

Laura Biganzoli, Tanja Čufer, P.F. Bruning et al. · Journal of Clinical Oncology · 2002 · 216 citations